MedPath

Pilot urinary markers and fetal growth restriction.

Registration Number
NL-OMON29020
Lead Sponsor
Stimuleringsfonds verloskunde (kleine vis-grote vis)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Inclusions in 5 groups , with n=12 in every group.

-Group 1 Pregnant women 18-40 yr with FGR and without hypertension (between 24 and 36 weeks of gestation):

Exclusion Criteria

oCongenital anomalies

oBeing unable to understand the study information either caused by
language differences or low IQ

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary and blood metabolites related to fetal growth restriction (birthweight and other parameters of growth restriction in the neonate)
Secondary Outcome Measures
NameTimeMethod
oDoppler patterns in umbilical artery and median cerebral artery (MCA)<br /><br>ocomposite neonatal outcome<br /><br>ocomposite maternal outcome<br /><br>oplacental findings<br /><br>oplacental bed findings<br /><br>omethylation differences<br /><br>oimmunologic differences
© Copyright 2025. All Rights Reserved by MedPath